Unity Biotechnology, Inc. (0YC0.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 16.2M |
| Enterprise Value | 32.16M |
| P/E Ratio | -0.13 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.52 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.77 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | -1.49 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -867,000 |
| EBITDA | -25.12M |
| Net Income | -25.99M |
| Diluted EPS | -1.54 |
Balance Sheet
| Total Cash | 16.93M |
| Total Cash/Share | 1.38 |
| Total Debt | 22.58M |
| Total Debt/Equity | 3.62 |
| Current Ratio | 2.62 |
| Book Value Per Share | 0.39 |
Price History
| 52-Week Change | -95.45 |
| 52-Week High | 3.79 |
| 52-Week Low | 0.06 |
| Moving Average 50 Days | 1.83 |
| Moving Average 200 Days | 2.31 |
Statistics
| Average Volume | 551 |
| Shares Outstanding | 17.21M |
| % Held by Institutions | 0.16 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 30, 2023 |
AD
